Sino Biopharmaceutical Limited Stock Today
| SBMFF Stock | USD 0.45 0.03 7.14% |
PerformanceModest
| Odds Of DistressLow
|
Sino Biopharmaceutica is trading at 0.45 as of the 26th of March 2025. This is a 7.14 percent increase since the beginning of the trading day. The stock's lowest day price was 0.45. Sino Biopharmaceutica has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.. The company has 18.81 B outstanding shares. More on Sino Biopharmaceutical Limited
Moving against Sino Pink Sheet
Sino Pink Sheet Highlights
| Chairman | Fai Chia |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Sino Biopharmaceutical Limited [SBMFF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sino Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Sino Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sino Biopharmaceutical classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 18.81 B outstanding shares.
Sino Biopharmaceutical Limited has accumulated about 15.67 B in cash with 5.37 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sino Biopharmaceutica Probability Of Bankruptcy
Ownership AllocationSino Biopharmaceutical shows a total of 18.81 Billion outstanding shares. Sino Biopharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sino Ownership Details
Sino Biopharmaceutical Risk Profiles
| Mean Deviation | 0.6181 | |||
| Standard Deviation | 2.26 | |||
| Variance | 5.13 | |||
| Risk Adjusted Performance | 0.0544 |
Sino Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sino Biopharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Other Information on Investing in Sino Pink Sheet
Sino Biopharmaceutica financial ratios help investors to determine whether Sino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sino with respect to the benefits of owning Sino Biopharmaceutica security.